GlassScriptPhysician profile
Alexander M Case
NPI 1154983930
$2,160.76
in general payments reported to CMS, 2019-2025
16 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.41 · 2022: $460 · 2023: $677 · 2024: $705 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,627.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,051.30 | 2021-2024 | |
| Ardelyx, INC. | $278.03 | 2022-2024 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $161.07 | 2024-2025 | Dupixent |
| Genzyme Corporation | $143.56 | 2023-2025 | |
| Pfizer INC. | $119.28 | 2022-2024 | |
| Madrigal Pharmaceuticals | $114.02 | 2024 | Resmetirom |
| Celgene Corporation | $68.83 | 2022 | |
| Janssen Biotech, INC. | $40.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.52 | 2022-2024 | Eohilia |
| Merck Sharp & Dohme LLC | $36.61 | 2023 | Dificid |
| Lilly USA, LLC | $22.04 | 2024 | Omvoh |
| Boston Scientific Corporation | $21.09 | 2025 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.84 | 2022 | |
| Aimmune Therapeutics, INC. | $17.68 | 2024 | |
| Ferring Pharmaceuticals INC. | $14.52 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $13.18 | 2023 | Ocaliva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.